Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 20, 2012
Boston Scientific will webcast its conference call with financial results for Q4 and full year ended December 31, 2011. Learn how to tune in or watch the replay.
-
Jan 16, 2012
Nine-month data presented at ISET support safety and efficacy of Epic Stent in iliac stenting
-
Jan 4, 2012Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
CMS pass-through payment and new CPT®[1] codes established for catheter-based procedure to treat severe asthma.
-
Jan 3, 2012
Boston Scientific will participate in the healthcare conference on January 11, 2012. Learn how to watch the webcast or replay.
-
Dec 12, 2011
Boston Scientific's third new peripheral balloon catheter introduced in 2011 strengthens Company's position as a global leader in peripheral angioplasty balloons.
-
Dec 8, 2011World's first and only 16-contact percutaneous lead provides innovative, new option for physicians to treat chronic pain
Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval of the Infinion™ 16 Percutaneous...
-
Nov 30, 2011
Extended ICD/CRT-D program offers warranties up to 10 years
-
Nov 30, 2011
New family of cardiac devices offers excellent longevity and industry's longest warranty.
-
Nov 22, 2011
Approval marks transition to internally manufactured everolimus-eluting stent in the U.S.
-
Nov 18, 2011
Boston Scientific will participate in the healthcare conference on November 30, 2011. Learn how to watch the webcast or replay.
-
Nov 16, 2011
Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke.
-
Nov 15, 2011
Legislation seeks to improve the ability of companies like Boston Scientific to safely, efficiently and predictably bring new technologies to market.
-
Nov 11, 2011
Positive results from COBRA trial presented at TCT
-
Nov 11, 2011
EVOLVE trial evaluates fourth-generation everolimus-eluting coronary stent with ultra-thin abluminal bioabsorbable polymer.
-
Nov 8, 2011
Carotid WALLSTENT shown to be a safe alternative to carotid endarterectomy (CEA) in patients with carotid artery stenosis who are at increased risk for surgery.
-
Nov 8, 2011
PLATINUM Long Lesion clinical results presented at TCT show no cardiac death, heart attack or stent thrombosis at one year.
-
Nov 8, 2011
Long-term results presented from two studies evaluating advanced paclitaxel-eluting stent.
-
Nov 2, 2011
Multi-center study published in Gastrointestinal Endoscopy is largest ever reported on peroral cholangioscopy.
-
Nov 1, 2011
Clinical presentations to include 12-month data on fourth-generation SYNERGY™ Stent.
-
Oct 27, 2011
Video demonstration of CardioTeach™ app by Dr. Kenneth Stein available online
-
Oct 20, 2011
“Boston Scientific’s POWER strategy is the right top priority for the entire leadership team," said CEO Hank Kucheman.
-
Oct 18, 2011
BWallFlex study includes patients with bile duct strictures associated with post liver transplant anastomosis, prior abdominal surgery and chronic pancreatitis.
-
Oct 17, 2011
Company's everolimus-eluting platinum chromium stent now being marketed in world's second-largest DES market.
-
Oct 14, 2011
Legislation is intended to streamline the medical device review and approval process, reduce regulatory delays and help new medical technologies safely and more expeditiously reach patients.
-
Oct 11, 2011
Boston Scientific will webcast its conference call with financial results and business highlights for Q3 2011 on Thursday, October 20. Learn how to tune in.